Cancer Types
- Appendix
- Bladder
- Bone
- Brain
- Breast
- Cervical
- Childhood cancers
- Endometrial
- Esophageal
- Eye
- Gallbladder
- Gastrointestinal
- Colon cancer
- Colorectal
- Gastrointestinal Carcinoid Tumor
- Small Intestine
- Stomach
- Head and Neck
- HIV and AIDS Related
- Kaposi Sarcoma
- Kidney
- Leukemia
- Liver
- Lung
- Lymphoma
- Mesothelioma
- Metastatic
- Multiple Myeloma
- Nasopharyngeal
- Oral
- Metastatic Cancer
- Ovarian
- Pancreatic
- Parathyroid
- Penile
- Prostate
- Rectal
- Recurring Cancers
- Sarcomas
- Secondary (Metastatic)
- Skin
- Squamous Cell
- Testicular
- Thyroid
- Vaginal
- Vulvar
Symptom Management
Treatment Types
- Adjuvant Chemotherapy
- Biological Therapy
- Cesium Chloride
- Chemotherapy
- Abraxane
- Bisphosphonate
- Bleomycin
- Cyclophosphamide
- Dacarbazine
- Docetaxel (Taxotere)
- Doxorubicin (Adriamycin)
- Estramustine
- Etoposide
- Ifosfamide
- Mechlorethamine
- Mitoxantrone
- Oral Chemotherapy
- Paclitaxel (Taxol)
- Pixantrone (Pixurvi)
- Platinum-based chemotherapy
- Prednisone
- Procarbazine
- Tamoxifen
- Vinblastine
- Vincristine
- Vinorelbine
- Chemotherapy Regimens
- Clinical Trials
- Chemoprevention
- Cryosurgery
- Gene Therapy
- Gerson Therapy
- Hormone Therapy
- Laser Therapy
- Platinum-based Therapy
- Radiotherapy
- Surgery
- Targeted Therapies
- Pain Management
- Proton Therapy
- Radioimmunotherapy
- Transplants
- Vaccines
- Watchful Waiting
Topics
Prostate cancer treatment choices should consider social, ethnic background
According to researchers from Thomas Jefferson University Hospital, gay and minority men with prostate cancer experience a lower quality of life following treatment, and that ethnic and sexual preference-related factors should be taken into consideration when determinging the most suitable treatment plan.
“Different communities of men view the effects of prostate cancer treatments very differently,” said study co-author Edouard J. Trabulsi, M.D., of the Department of Urology and Kimmel Cancer Center at Thomas Jefferson University Hospital.
Among those factors are, for instance, the increased risk of urinary and bowel function decline in African Americans regardless of the treatment types they receive, thefact that they have higher prostate cancer incidence and mortality rates than whites, and are less likely to initiate and complete treatment and less likely to trust a physician. Among gay men, there are widely differing sexual expectations and social support compared to other groups.
“It’s in the patient’s best interest for caregivers to acknowledge perceptions and expectations during the treatment decision process,” continued Dr. Trabulsi. “They should take specific demographics, socioeconomic status, and sexual preference into consideration, and tailor an approach based on a patient’s specific concerns about the implications of various treatments.”
Source: Newswise
The information provided on CancerTreatment.net is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational purposes and does not constitute the practice of medicine. We encourage all visitors to see a licensed physician or nutritionist if they have any concerns regarding health issues related to diet, personal image and any other topics discussed on this site. Neither the owners or employees of CancerTreatment.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.